3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Neoplasms
5
Mycoses
4
Leukemia, Myeloid, Acute
4
Recurrence
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma
3
Leukemia
3
Infections
3
Neutropenia
2
Multiple Myeloma
2
Lymphoma, Mantle-Cell
2
Lymphoma, B-Cell, Marginal Zone
2
Wilms Tumor
1
Triple Negative Breast Neoplasms
1
Testicular Neoplasms
1
Teratoma, Testicular
1
Teratoma
1
Stem Cell Transplant Complications
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumours
1
Sezary Syndrome
1
Seminoma
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Neuroblastoma
1
Neoplasm Metastasis
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Interventions
Trimethoprim, Sulfamethoxazole Drug Combination
1
Trimethoprim
1
Nitrofurantoin
1
Linezolid
1
Fluconazole
1
Ciprofloxacin
1
Cefuroxime
1
Amoxicillin-Potassium Clavulanate Combination
1
Amoxicillin
1
Amdinocillin Pivoxil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Cystectomy
×
Fluconazole
×
Clear all
NCT06709196
2025-01-09
REINFORCE
Rigshospitalet, Denmark
Phase 4
Recruiting
248 enrolled